This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marchbanks, C. R. Articles by Rowley, K. A. Search for Related Content Social Bookmarking                         What's this?

Update on Infections in the Immunocompromised Host

Antiinfective Pharmacology Research Unit, Roger Williams Medical Center, Providence, RI, The University of Rhode Island, College of Pharmacy; Providence.

Karen A. Rowley

Antiinfective Pharmacology Research Unit, Roger Williams Medical Center, Providence, RI, The University of Rhode Island, College of Pharmacy; Providence.

Recent advances in medical care have provided more effective therapies for the treatment of various malignancies and increased the number of successful bone marrow and organ transplantations. However, these advances often place the patient in a severely immunocompromised state for several days or weeks resulting in one or more life-threatening infections. This article discusses some general principles, current pharmacotherapeutic strategies, and novel treatment strategies for the management of immunocompromised patients.

Journal of Pharmacy Practice, Vol. 4, No. 5, 282-294 (1991)
DOI: 10.1177/089719009100400502


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?